EVENT
[Open Seminar] Harvey Lodish, Ph.D.
June 19, 2024
Credits: WPI-Bio2Q
Credits: WPI-Bio2Q
Credits: WPI-Bio2Q
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) held an open seminar as follows:
| Date & Time | Wednesday, June 12, 2024, 16:00 -17:30 |
|---|---|
| Venue | (Hybrid) 1F Lounge, Center for Integrated Medical Research, Shinanomachi Campus, Keio University and on zoom |
| Title | New Technologies and Building Successful Biotechnology Companies to Treat Disease: A Personal History |
| Speaker | Harvey F. Lodish, Ph.D. Professor of Biology and Professor of Biological Engineering, Massachusetts Institute of Technology (USA) Lead author, “Molecular Cell Biology” Founder/scientific board member: Genzyme, Millennium Pharmaceuticals, Rubius Therapeutics, Tevard |
| Language | English |
Prof. Lodish highlighted the connection between academia and entrepreneurship in biotechnology, covering key aspects of starting a biotech company, intellectual property, and assembling a team with diverse expertise. The importance of scientists leveraging their expertise by consulting for or founding companies and the advantage of research institutes being located near biotech companies for collaboration was also discussed.
SHARE
More Bio2Q News
【Publication】Lysophosphatidic acid drives to mirror-image pain via corpus callos...
Co-authored by Bio2Q researchers and published in Communications Biology, this study clarifies how lysophosphatidic acid (LPA) propagates in...
【Publication】Parallelizable search-space decomposition for large-scale combinato...
Co-authored by Bio2Q researchers (Scientific Reports), this study significantly accelerates large-scale optimization by splitting problems f...
Bio2Q to Participate and Exhibit at the 15th WPI Science Symposium
The 15th WPI Science Symposium will be held on Saturday, November 14, 2026, at the Osaka University Suita Campus Convention Center. This ...
【Publication】Mitochondria-targeting ACSL6 variant drives mitochondrial fragmenta...
Co-authored by researchers from Bio2Q and published in Scientific Reports, this study reveals how a short ACSL6 enzyme variant selectively t...
【Publication】bifidoAnnotator: fine-grained annotation of bifidobacterial glycosi...
Co-authored by Bio2Q researchers and published in Microbial Genomics, this study presents "bifidoAnnotator," a tool designed for the highly ...
